Reilly C P, Symons R G, Wellby M L
J Endocrinol Invest. 1986 Oct;9(5):367-70. doi: 10.1007/BF03346944.
Thyrotoxic patients treated with Iodine-131 (131I) often present with low thyroxine (T4), normal triiodothyronine (T3) and raised thyrotropin (TSH) concentrations in serum. We have developed a rat model of this low T4, raised TSH state. Rats were injected with 50, 150 or 450 mu Ci 131I. A dose of 50 mu Ci 131I caused no significant effect on thyroid function, as assessed by serum parameters whereas both 150 mu Ci and 450 mu Ci 131I caused a significant fall in serum T4 concentration accompanied by a significant rise in TSH concentration. In all groups serum T3 concentration was not significantly altered when compared to controls. The clearance of 131I from the rats showed a single exponential curve (t 1/2 3.38 +/- 0.61 days) over the range of 131I doses used. Differing body weights had no effect on the serum T4 changes induced by 131I.
接受碘 - 131(¹³¹I)治疗的甲状腺毒症患者血清中常出现甲状腺素(T4)降低、三碘甲状腺原氨酸(T3)正常及促甲状腺激素(TSH)浓度升高的情况。我们建立了这种低T4、高TSH状态的大鼠模型。给大鼠注射50、150或450微居里的¹³¹I。50微居里¹³¹I剂量对甲状腺功能无显著影响,通过血清参数评估,而150微居里和450微居里¹³¹I均导致血清T4浓度显著下降,同时TSH浓度显著升高。与对照组相比,所有组血清T3浓度均无显著变化。在所使用的¹³¹I剂量范围内,¹³¹I从大鼠体内的清除呈单指数曲线(半衰期3.38±0.61天)。不同体重对¹³¹I诱导的血清T4变化无影响。